Related Experiment Videos
Antral G-cell hyperplasia: a vanishing disease?
1Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, Netherlands.
European Journal of Gastroenterology & Hepatology
|November 1, 1995
Summary
Helicobacter pylori eradication normalizes gastrin levels and antral G-cell hyperplasia. This treatment is key for H. pylori-positive cases, though H. pylori-negative conditions also exist.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Antral gastrin (G-) cell hyperplasia was a significant focus before Helicobacter pylori discovery.
- H. pylori infection's link to hypergastrinaemia and normalization post-eradication revived interest in G-cell hyperplasia.
Purpose of the Study:
- To review the historical context of antral G-cell hyperplasia.
- To examine the relationship between H. pylori and antral G-cell hyperplasia.
- To discuss current management strategies, including H. pylori eradication.
Main Methods:
- Review of historical literature.
- Analysis of recent case reports.
- Examination of the association between H. pylori infection and antral G-cell hyperplasia.
Main Results:
- H. pylori infection is found in approximately 50% of antral G-cell hyperplasia cases.
- Eradication of H. pylori normalizes both gastrin levels and antral G-cell counts.
- H. pylori-negative antral G-cell hyperplasia or hyperfunction is also recognized.
Conclusions:
- H. pylori eradication is the preferred treatment for associated antral G-cell hyperplasia.
- Understanding the interplay between H. pylori and G-cells is crucial for managing hypergastrinaemia.
- Further research into H. pylori-negative cases may reveal alternativepathogenic mechanisms.